Key facts
- It has raised $3.8M; the latest was Early Stage VC in Apr 2026.
- Notable investors include High-Tech Gründerfonds, Kinled Holding, IBB Ventures, BIF Partners, Business Angels Club Berlin-Brandenburg — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Nuuron
- ·The full record, as it builds
Funding rounds
No funding rounds for Nuuron are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nuuron
Developer of digital memory pacemaker intended to re-enable patients with Alzheimer's disease to store and recall memories again. The company's platform algorithms produce ultra-high frequency, digital photonic stimuli that activate the memory center by using the retina as a computer-brain interface, enabling patients to improve the storage and retrieval of information.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2023
- Employees
- 7
- Website
- nuuron.com/
- Ownership
- Privately Held (backing)
Nuuron doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nuuron shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nuuron in its N-PORT filings yet. We sweep new filings monthly.